Immune Thrombocytopenic Purpura Market to Grow at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight
The recent approval of Sanofi’s WAYRILZ has shifted the dynamics of the immune thrombocytopenic purpura market. This approval has also…